Screening of chemokines by proteome profiler assay showed that CXCL10, CCL2, CCL3/4, CCL9/10, CCL5, and CCL12 expression were higher in BV2 CML than in control. This evidence concerns the gene CCL3 and chronic myelogenous leukemia, BCR-ABL1 positive.